Prelude Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Prelude Therapeutics's estimated annual revenue is currently $27.3M per year.
- Prelude Therapeutics's estimated revenue per employee is $155,000
- Prelude Therapeutics's total funding is $58M.
Employee Data
- Prelude Therapeutics has 176 Employees.
- Prelude Therapeutics grew their employee count by 3% last year.
Prelude Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | President and Chief Medical Officer | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Legal Officer | Reveal Email/Phone |
6 | Executive Assistant to President and CMO | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Chief People Officer | Reveal Email/Phone |
9 | VP Business Development | Reveal Email/Phone |
10 | SVP & Head Strategic Planning & Operations | Reveal Email/Phone |
Prelude Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Prelude Therapeutics?
$58M
Total Funding
176
Number of Employees
$27.3M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prelude Therapeutics News
2022-03-22 - Prelude Therapeutics to Participate at the Barclays 2022 ...
WILMINGTON, Del., March 11, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company,...
2022-03-22 - Prelude Therapeutics Reports Full Year 2021 Financial Results
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell...
2022-03-22 - Prelude Therapeutics Provides Clinical Update and ...
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.2M | 176 | 29% | N/A |
#2 | $7.5M | 176 | N/A | N/A |
#3 | $42.6M | 176 | N/A | N/A |
#4 | $29M | 176 | 0% | N/A |
#5 | $28.1M | 176 | 6% | N/A |